Immunosuppressive therapy for the eye changes of Graves' disease.
D000328:Adult; D000368:Aged; D000917:Antibody Formation; D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003228:Conjunctiva; D004172:Diplopia / Q000188:drug therapy*; D005094:Exophthalmos / Q000188:drug therapy*; D005132:Eye Manifestations / Q000188:drug therapy*; D005260:Female; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G; D008135:Long-Acting Thyroid Stimulator; D008297:Male; D008875:Middle Aged; D009578:Nitrobenzenes; D012882:Skin Tests; D013745:Tetanus Toxoid / Q000037:antagonists & inhibitors; D013960:Thyroid Function Tests
D007074:Immunoglobulin G; D009578:Nitrobenzenes; D013745:Tetanus Toxoid; D008135:Long-Acting Thyroid Stimulator; D001379:Azathioprine